Terrance McGuire, Director at Cyclerion Therapeutics, Inc. (CYCN), bought 188,984 shares at $3.12 ($590K) on 2021-06-03, disclosed to the SEC on 2021-06-07.
Open-market purchase of $590k CYCN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.12 | 3,322 | $10K | 1.8% |
| 2 | $3.12 | 92,831 | $290K | 49.1% |
| 3 | $3.12 | 92,831 | $290K | 49.1% |
| Total | $3.12 avg | 188,984 | $590K | 100% |
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |